Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. - Wikidata - wikimedia - TriplyDB

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

http://www.wikidata.org/entity/Q36403539

about

Cancer immunoediting from immune surveillance to immune escape Radiotherapy combination opportunities leveraging immunity for the next oncology practice Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines Immune Evasion Strategies of Glioblastoma Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man Role of Dendritic Cells in the Induction of Lymphocyte Tolerance Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data Regulatory T cell: a protection for tumour cells Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells Control of the immune response by pro-angiogenic factors Suppression, subversion and escape: the role of regulatory T cells in cancer progression Stimulating antitumor immunity with nanoparticles Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity Immunosuppression associated with chronic inflammation in the tumor microenvironment Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice Regulatory dendritic cells: there is more than just immune activation Myeloid-derived cells are key targets of tumor immunotherapy Orchestration of angiogenesis by immune cells Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer Coordinated regulation of myeloid cells by tumours Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells Tumor masses support naive T cell infiltration, activation, and differentiation into effectors Strategies and challenges in eliciting immunity to melanoma.CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells TGF-β signaling in myeloid cells is required for tumor metastasis.P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg.Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.Antitumor activity of total flavonoids from Tetrastigma hemsleyanum Diels et Gilg is associated with the inhibition of regulatory T cells in mice.Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice.Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo.Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells.Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

P2860

Q24655415-1E1E43B6-B417-4196-93F3-09768A95E90F Q26738443-366B2802-9CCD-4A8A-BB25-CF05F05771CE Q26740513-9A18C134-EC58-4CE8-812C-27CC0F5959B5 Q26765855-98F4EC7F-C75B-4EE5-B899-D95A12C0BDB3 Q26774345-71B21AEC-1B78-46D5-B299-B6B3D24439AF Q26776126-3B2746E7-4A2B-4157-A10E-D49EEAE8F3BF Q26779405-68DE3AE6-C2E4-4E35-8A57-B59AF80CB8CD Q26781098-388695A1-A559-491F-8897-B64605774048 Q26991447-29FFE33E-6A00-47FC-AAFB-73BA0DD4C4BD Q26996742-2BD619DE-F4D4-4BFE-9833-885244087E51 Q27004733-43E9C45D-F49E-4153-8092-C3F4CD262F31 Q27026151-A441911D-441A-4499-8854-54B4D97B97E5 Q27027780-5A78D2E2-8E6E-4A5D-B396-72E112ED519D Q28068106-3EA16E12-1A81-4B6C-B184-C66CF20E7324 Q28075996-3216A2BF-C7D0-4BE1-B771-9F92E4ADDCF1 Q28083450-A5FCCE7F-856E-4A66-8A7A-A2D063128DA4 Q28385532-DF8440BE-256B-472E-BB78-3340228CC06F Q28388235-EC6CE9EB-B79B-40BD-A2DC-3CC75D1B109A Q28388246-712033DB-1474-44DF-A053-68976B7AC46E Q28389236-9B6EE979-B7F2-4DE6-9A6C-62231A23324E Q28390368-9C76E129-8E9A-4AEE-BAD4-B8D10873957B Q28392626-5285D049-3D3A-4A85-85D7-EA08FE4A2181 Q28395157-E4FCDCB7-C170-4561-8B9F-5C07CA1F6170 Q28533749-9C2C6BFB-8816-44C9-AA2C-DF10727E575B Q30433292-1FB78762-A54A-4051-9C55-0E500F1D942C Q30435893-86464FFA-2D18-4D6D-9FB6-630349CB79CB Q33268298-A1ED8A56-76A0-48E0-B17B-5CDFA67D66E8 Q33326987-CE8E30F1-55BE-488E-9EE6-DB61EA546AB3 Q33355832-E228952B-23CE-4674-A6F3-D7E6747A71C2 Q33373059-521C4F7A-D3EA-46B8-8C17-C18F3A62D5CE Q33414811-DDAD0AF9-464E-4513-9D0D-E32DBC5DB225 Q33509292-0EDCB651-24C4-4679-8ED2-373490F77B5F Q33631922-A70054E6-E56C-4365-BD1B-D71791E57EFD Q33736218-F6D7F2C6-A3C0-46BD-A387-C7EAD4A6E832 Q33769458-1356360F-D654-41AB-9E9A-A1773DA15914 Q33770707-B5A2C570-DE84-4B02-BF72-DC5EFF233E99 Q33858506-7055B7C3-B71D-43B8-80AD-1814ECF8A483 Q33886184-2805E67B-F0B5-426C-8E57-9E81A004DAE1 Q33890964-5F8A09EA-DD80-47E6-B767-2C89746461C5 Q33903144-20425CE8-191D-45FF-B501-1F9B2BAA1737

P2860

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

http://www.wikidata.org/entity/Q36403539

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Tumor cells convert immature m ...... gulatory T cell proliferation.

@ast

Tumor cells convert immature m ...... gulatory T cell proliferation.

@en

type

label

Tumor cells convert immature m ...... gulatory T cell proliferation.

@ast

Tumor cells convert immature m ...... gulatory T cell proliferation.

@en

prefLabel

Tumor cells convert immature m ...... gulatory T cell proliferation.

@ast

Tumor cells convert immature m ...... gulatory T cell proliferation.

@en

P1433

Q36403539-CD683156-3E45-4906-A12B-07A20E291E45

P1476

Q36403539-28EDD5BB-117B-4151-B5F5-9CD411847B14

P2093

Q36403539-26450372-158B-4BCB-8FD4-80319F30A07B

Q36403539-2B6DF0BA-6B54-4C3E-9D62-89ADD9D28090

Q36403539-529C11F9-1B7A-4779-BD8A-25B6C968CDD2

Q36403539-80A00325-D3FC-41DF-9A87-CB7B2974BFC5

P2860

Q36403539-05F64265-55E7-4AF5-A962-96B9F93CCD93

Q36403539-07B16411-874C-4579-ACF8-023C8DDB3884

Q36403539-4B279EC6-8DD0-45A8-B114-50688CFA663F

Q36403539-4B3DB238-AE0D-433A-9D4E-0458F5A72FFF

Q36403539-6AB895AD-1E58-41D3-9985-EE63DD9DA646

Q36403539-73AF9791-1731-4032-85F4-71827000B0E8

Q36403539-7798E650-5B6A-4603-832F-C81B953B1DBA

Q36403539-7C89B65B-5662-4125-9326-9A1E28E85896

Q36403539-7E38DADB-1C62-4316-A5FD-CA907B893CB9

Q36403539-8A2743CD-0B67-49CC-A4BA-4F83E10DEE54

P304

Q36403539-683E4592-1D4E-417B-B453-0E9EAEDB4BA2

P31

Q36403539-52925EBF-DC87-4853-98B3-3422D707D3BC

P356

Q36403539-36338C60-C067-4E34-97F8-1231AB0DAA27

P407

Q36403539-E103E3DE-FB9A-4288-8CAB-159458C4BEFA

P433

Q36403539-C93D300A-1A8D-40DB-ACE1-3617AF6DD8BB

P478

Q36403539-B9F3ADA1-92A1-4ADE-AAE2-DDA27AA35A60

P50

Q36403539-24DB7F96-979E-4823-95DD-7461A2EACADA

Q36403539-26EC2384-205B-4A4B-8D08-E8908C50A892

Q36403539-838ABE09-4036-4EE2-93D2-2F67A11C35AF

Q36403539-B2C75308-195F-4916-835D-247D7DB69D69

Q36403539-C0AE1849-F816-4D89-A81C-ECBBB6DF2696

Q36403539-F8158A81-7E0D-4B4E-B8DF-EB9E959C7336

P577

Q36403539-52430406-3F94-4549-BFA5-DF581B5165FD

P5875

Q36403539-5065C397-A7E9-493A-8415-776E0332985C

P698

Q36403539-30E30461-612A-43BB-A029-70DAF6F4C904

P932

Q36403539-5E16E44E-5F25-4D7E-B93E-4A1551B1F823

P356

P1433

Journal of Experimental Medicine

P1476

Tumor cells convert immature m ...... gulatory T cell proliferation.

@en

P2093

Arnaud Parcellier

http://www.w3.org/2001/XMLSchema#string

Elise Schmitt

http://www.w3.org/2001/XMLSchema#string

Pierre E Puig

http://www.w3.org/2001/XMLSchema#string

Stephan Roux

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

Regulatory T cells: key controllers of immunologic self-tolerance.

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

P304

919-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050463

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

François Ghiringhelli

Bruno Chauffert

François Martin

P577

2005-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7578600

http://www.w3.org/2001/XMLSchema#string

P698

16186184

http://www.w3.org/2001/XMLSchema#string

P932

2213166

http://www.w3.org/2001/XMLSchema#string